Gelteq Limited (GELS)
0.51
0.00 (0.00%)
Upcoming Events
Latest Headlines
Gelteq opens China center to boost drug development operations
June 4, 2026 9:08 AM - StreetInsider
Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion
June 4, 2026 9:08 AM - Globe NewsWire
Form 6-K Gelteq Ltd For: Jun 02
June 2, 2026 4:05 PM - SEC Filing
Form 6-K Gelteq Ltd For: May 26
May 26, 2026 4:14 PM - SEC Filing
Gelteq begins veterinary clinical trial for antiparasitic drug candidate
May 20, 2026 8:01 AM - StreetInsider
Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway
May 20, 2026 8:00 AM - Globe NewsWire
Healthy Extracts Q1 2026 Net Revenue Up 73% to Record $1.6 Million, Driving Positive EBITDA
May 14, 2026 8:42 AM - StreetInsider
Gelteq secures $3.5 million debt financing for commercialization
May 12, 2026 8:03 AM - StreetInsider
Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth
May 12, 2026 8:00 AM - Globe NewsWire
Healthy Extracts Reports 2025 Net Revenue Up 45% to Record $4.5 Million
April 8, 2026 4:05 PM - StreetInsider
Healthy Extracts Reports Preliminary 2025 Results, Net Revenue Expected Up 45% to Record $4.5 Million
April 2, 2026 6:55 AM - StreetInsider
Q1 Virtual Investor Summit Presentations Now Available On Demand
March 26, 2026 3:48 PM - StreetInsider
Form 6-K Gelteq Ltd For: Mar 24
March 24, 2026 8:16 AM - SEC Filing
Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26)
March 20, 2026 8:00 AM - StreetInsider
Form 3 Gelteq Ltd For: Mar 18 Filed by: WYNNE Paul Michael
March 18, 2026 8:17 PM - SEC Filing
Form 3 Gelteq Ltd For: Mar 18 Filed by: Szewach Simon H
March 18, 2026 8:16 PM - SEC Filing
Form 3 Gelteq Ltd For: Mar 18 Filed by: Karp Bradley Glenn
March 18, 2026 7:19 PM - SEC Filing
Form 3 Gelteq Ltd For: Mar 18 Filed by: Givoni Nathan J
March 18, 2026 7:17 PM - SEC Filing
Full Article List
